Volume  Number

previous article

next article

The effect of mirtazapine on methotrexate-induced oxidative damage and infertility in rats

Omer Erkan Yapca^a, Bunyamin Borekci^b, Mehmet Ibrahim Turan^c,*, Mine Gulapoglu^d, Suleyman Salman^e

 
ABSTRACT:     Methotrexate (MTX) is a folic acid antagonist and common chemotherapeutic drug. This study investigated the effectiveness of mirtazapine in preventing infertility developed by MTX-associated oxidative damage. In addition, we demonstrate an association between oxidative stress in ovarian tissue induced by MTX and infertility. Rats were divided into three groups: MTX control, mirtazapine+MTX, and healthy control. At the end of the procedures the reproductive function was noted and ovaries extracted to determine malondialdehyde (MDA Moncler women jacket), myeloperoxidase (MPO), and total glutathione (GSH) levels. MDA concentration in ovarian tissue in the control group given MTX was 13.7±2.1 µmol/g protein. In the mirtazapine+MTX group and healthy control group the levels were 7.5±1.9 and 4.0±1.4 µmol/g protein, respectively. MPO activity in the control group given MTX, mirtazapine+MTX, and healthy control groups was 17.8±4.7, 7.5±2.4, and 5.2±1.7 µmol/g protein, and GSH levels 4.5±2.1, 11.8±3.9, and 14.7±4.7 nmol/g protein, respectively. The study also demonstrated an association between oxidative stress induced by MTX in ovarian tissue and infertility. The mirtazapine used prevented MTX-associated infertility. There were no live births in the control group given MTX alone. However, only one of the 10 rats kept for reproduction did not give birth in the mirtazapine+MTX (end of the procedure only given mirtazapine) group. In conclusion, mirtazapine can be used to prevent infertility appearing in patients receiving MTX therapy.

Download PDF

26 Downloads 1474 Views

* Corresponding author, E-mail: turan78tr@hotmail.com

Received 15 Jun 2013, Accepted 6 Mar 2014